Cancer Institute VOU, Rastislavova

Košice 040 01

0 studies enrolling now · 1 studies all time

What they study most

Breast Cancer, Breast Neoplasm, Triple-Negative Breast Cancer, Triple-Negative Breast Neoplasms

Studies at this site

• Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Gemcitabine and Carboplatin in Metastatic Triple Negative Breast Cancer (mTNBC) — Stopped early